There are four GLP-1 FDA decisions to watch in 2026 Eli Lillys injectable Mounjaro, with a new indication to reduce the risk of major adverse cardiovascular events in patients with T2DM, is expected in mid-2026
The fecal metabolome as a functional readout of the gut microbiome
Understanding the typical timeline helps set realistic expectations and prepares you for the journey ahead
Potential Side Effects: Nausea, diarrhoea, or constipation are common side effects, especially during the initial stages of treatment
Stopping medication doesnt mean failure it means you and your clinician are adjusting your approach
In cancer cells, the use of glutamate-derived nitrogen for NEAA production may be favored in various types of cancer cells to preserve nitrogen for anabolic reactions 48 and may prevent apoptosis induced by ATF4 activation upon glutamine deprivation 6